Methods (AMACR)

Matthew Lloyd (Inventor), Maksims Jevglevskis (Inventor), Guat Ling Lee (Inventor), Timothy Woodman (Inventor), Michael Threadgill (Inventor)

Research output: Patent

Abstract

A method of measuring α-methylacyl-CoA racemase (AMACR) activity in a sample is described comprising the steps of: (i) providing a sample; (ii) contacting said sample with a substrate compound that undergoes elimination of hydrogen and a leaving group catalysed by said AMACR to produce a product compound having an additional carbon- carbon double bond; and (iii) measuring the amount of said leaving group and/or of said product compound and/or of unreacted substrate compound. Also provided are methods of diagnosis and medical imaging, in particular for use in diagnosing prostate cancer. Also provided are substrate compounds of Formula 1 for use in the methods described herein.
LanguageEnglish
Patent numberEP3102694 A1
Priority date3/02/14
StatusPublished - 14 Dec 2016

Cite this

Lloyd, M., Jevglevskis, M., Lee, G. L., Woodman, T., & Threadgill, M. (2016). Methods (AMACR). (Patent No. EP3102694 A1).

Methods (AMACR). / Lloyd, Matthew (Inventor); Jevglevskis, Maksims (Inventor); Lee, Guat Ling (Inventor); Woodman, Timothy (Inventor); Threadgill, Michael (Inventor).

Patent No.: EP3102694 A1.

Research output: Patent

Lloyd, M, Jevglevskis, M, Lee, GL, Woodman, T & Threadgill, M 2016, Methods (AMACR), Patent No. EP3102694 A1.
Lloyd M, Jevglevskis M, Lee GL, Woodman T, Threadgill M, inventors. Methods (AMACR). EP3102694 A1. 2016 Dec 14.
Lloyd, Matthew (Inventor) ; Jevglevskis, Maksims (Inventor) ; Lee, Guat Ling (Inventor) ; Woodman, Timothy (Inventor) ; Threadgill, Michael (Inventor). / Methods (AMACR). Patent No.: EP3102694 A1.
@misc{1f933d45b187406492adad281e8af41c,
title = "Methods (AMACR)",
abstract = "A method of measuring α-methylacyl-CoA racemase (AMACR) activity in a sample is described comprising the steps of: (i) providing a sample; (ii) contacting said sample with a substrate compound that undergoes elimination of hydrogen and a leaving group catalysed by said AMACR to produce a product compound having an additional carbon- carbon double bond; and (iii) measuring the amount of said leaving group and/or of said product compound and/or of unreacted substrate compound. Also provided are methods of diagnosis and medical imaging, in particular for use in diagnosing prostate cancer. Also provided are substrate compounds of Formula 1 for use in the methods described herein.",
author = "Matthew Lloyd and Maksims Jevglevskis and Lee, {Guat Ling} and Timothy Woodman and Michael Threadgill",
year = "2016",
month = "12",
day = "14",
language = "English",
type = "Patent",
note = "EP3102694 A1",

}

TY - PAT

T1 - Methods (AMACR)

AU - Lloyd, Matthew

AU - Jevglevskis, Maksims

AU - Lee, Guat Ling

AU - Woodman, Timothy

AU - Threadgill, Michael

PY - 2016/12/14

Y1 - 2016/12/14

N2 - A method of measuring α-methylacyl-CoA racemase (AMACR) activity in a sample is described comprising the steps of: (i) providing a sample; (ii) contacting said sample with a substrate compound that undergoes elimination of hydrogen and a leaving group catalysed by said AMACR to produce a product compound having an additional carbon- carbon double bond; and (iii) measuring the amount of said leaving group and/or of said product compound and/or of unreacted substrate compound. Also provided are methods of diagnosis and medical imaging, in particular for use in diagnosing prostate cancer. Also provided are substrate compounds of Formula 1 for use in the methods described herein.

AB - A method of measuring α-methylacyl-CoA racemase (AMACR) activity in a sample is described comprising the steps of: (i) providing a sample; (ii) contacting said sample with a substrate compound that undergoes elimination of hydrogen and a leaving group catalysed by said AMACR to produce a product compound having an additional carbon- carbon double bond; and (iii) measuring the amount of said leaving group and/or of said product compound and/or of unreacted substrate compound. Also provided are methods of diagnosis and medical imaging, in particular for use in diagnosing prostate cancer. Also provided are substrate compounds of Formula 1 for use in the methods described herein.

UR - https://worldwide.espacenet.com/publicationDetails/inpadocPatentFamily?CC=WO&NR=2015114383A1&KC=A1&FT=D&ND=3&date=20150806&DB=&locale=en_EP

M3 - Patent

M1 - EP3102694 A1

ER -